Integrated services from medical-device sales through support
First written in FY2016. 11 of 19 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「The Smart Diaper System, a urinary care solution promoting digital transformation in nursing care, was registered with the Welfare Equipment Information System (TAIS) (20 January, Life Sciences Business)」
Service expansion in the medical and nursing care fields progressed from the basic sales and purchase agreement for smart urinary care products to registration of the Smart Diaper System with TAIS. - 2026-06-08Cited as achievedEarnings presentation materials
「Medical equipment maintenance services and ICT services grew」
The company cited growth in medical equipment maintenance services and ICT services as results in the Life Sciences business. - FY2026-H1AdvancedAnnual report
「Entered into a basic sales and purchase agreement for smart urinary care products with South Korea's HYGERA (7 August, Life Sciences Business)」
As part of its service expansion in the medical device field, the company entered into a basic sales and purchase agreement with a South Korean manufacturer for smart urinary care products. - FY2025-H1AdvancedAnnual report
「Launched a service for implementing and operating an environmental monitoring system compliant with ISO 15189, which demonstrates the reliability of clinical laboratories, and providing implementation and operations support (27 June release) (Life Sciences Business)」
For integrated services in the life sciences field, the company newly launched a service for implementing and operating an environmental monitoring system compliant with ISO 15189, with implementation and operations support. - FY2024AdvancedAnnual report
「Although demand from large spot projects declined, the ICT business in the life sciences field, where IT adoption is lagging, was expanding, so we focused on expanding that business.」
In the life sciences field, the company is focusing on expanding its ICT business in addition to its conventional services involving medical devices and other products. - FY2023AdvancedAnnual report
「For the fiscal year, revenue and profit increased year on year due to continued orders for spot projects involving medical devices.」
The life sciences services business recorded higher revenue and profit after continuing to receive orders for spot medical device projects. - FY2022AdvancedAnnual report
「For the fiscal year, revenue and profit increased because maintenance services for medical and chemical analysis equipment recovered and the medical ICT business expanded.」
Maintenance services for medical devices and chemical analysis equipment, together with market entry support, progressed to higher revenue and profit as the medical ICT business expanded. - FY2020-Q3AdvancedAnnual report
「We newly received contracts from a chemical analysis equipment manufacturer for maintenance services and support for implementing a laboratory information management system (LIMS) using IT, among other services.」
For integrated services in the medical and life sciences fields, the company newly received contracts for maintenance services for chemical analysis equipment and support for implementing LIMS. - FY2020-Q1AdvancedAnnual report
「Market demand for IT adoption in the medical device sector is expanding, and the number of projects won increased as a result of active sales efforts.」
The company disclosed that the number of projects won increased as a result of sales efforts in the medical device sector. - FY2019AdvancedAnnual report
「As a result, the number of orders for the one-stop service for medical devices compliant with the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices increased.」
The company disclosed an increase in orders for its one-stop service for medical devices compliant with the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices. - FY2018AdvancedAnnual report
「May 2017: Obtained a Class 1 medical device marketing authorization and registered as a medical device manufacturer」
In connection with the one-stop service covering medical device approval, importation, manufacturing, sales and support, the company completed obtaining a Class 1 medical device marketing authorization and registering as a medical device manufacturer. - FY2018-Q3RestatedAnnual report
「In addition, expenses were newly recorded to obtain business licenses for medical device manufacturing and marketing.」
The company continues to pursue the required licensing and record expenses toward obtaining licenses for medical device manufacturing and marketing. - FY2018-Q2RestatedAnnual report
「In addition, expenses were newly recorded to obtain business licenses for medical device manufacturing and marketing.」
Expenses continue to be recorded toward obtaining licenses for medical device manufacturing and marketing, and the company continues to address the required regulatory approvals. - FY2018-Q1Preparation for obtaining medical device regulatory approvalsAnnual report
「In addition, expenses were newly recorded to obtain business licenses for medical device manufacturing and marketing, resulting in」
Expenses have been recorded toward obtaining licenses for medical device manufacturing and marketing, and the company is advancing regulatory approvals for its one-stop service. However, the disclosure does not state that the licenses have been obtained. - FY2017RestatedAnnual report
「We will work to expand orders for a one-stop service for overseas medical device manufacturers covering medical device approval under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, as well as importation, manufacturing, sales and support.」
The company continues to pursue its policy of expanding orders for a one-stop service covering medical device approval, importation, manufacturing, sales and support. - FY2017-Q3RestatedAnnual report
「For overseas medical device manufacturers, we launched a one-stop service covering importation under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, as well as sales and support.」
The company continues to describe a one-stop service for overseas medical device manufacturers covering importation through sales and support. - FY2017-Q2RestatedAnnual report
「For overseas medical device manufacturers, we launched a one-stop service covering medical device approval under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, as well as importation, manufacturing, sales and support.」
The company continues to describe a one-stop service covering medical device approval, importation, manufacturing, sales and support. - FY2017-Q1AdvancedAnnual report
「For overseas medical device manufacturers, we launched a one-stop service covering medical device approval under the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices, as well as importation, manufacturing, sales and support.」
For medical devices, a one-stop service covering approval, importation, manufacturing, sales and support was launched. - FY2016First statedAnnual report
「Drawing on 30 years of experience in medical-device outsourcing, we will provide an integrated service, from sales through support, for manufacturers seeking to enter Japan and other Asian markets.」
Plans to use accumulated medical-device outsourcing expertise to support manufacturers entering Japan and Asia.